Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer
- PMID: 26208314
- PMCID: PMC4514651
- DOI: 10.1371/journal.pone.0130472
Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer
Abstract
Peritoneal metastasis is the most frequent type of recurrence in patients with gastric cancer (GC) and is associated with poor prognosis. Peritoneal lavage cytology, used to evaluate the risk of peritoneal metastasis, has low sensitivity. Here, we assessed the diagnostic potential of exosomal miRNA profiles in peritoneal fluid for the prediction of peritoneal dissemination in GC. Total RNA was extracted from exosomes isolated from six gastric malignant ascites (MA) samples, 24 peritoneal lavage fluid (PLF) samples, and culture supernatants (CM) of two human gastric carcinoma cell lines that differ in their potential for peritoneal metastasis. Expression of exosomal miRNAs was evaluated with Agilent Human miRNA microarrays and quantitative reverse transcription polymerase chain reaction (qRT-PCR). The microarray analysis indicated a low variability in the number and signal intensity of miRNAs detected among the samples. In the six MA fluids, miR-21 showed the highest signal intensity. We identified five miRNAs (miR-1225-5p, miR-320c, miR-1202, miR-1207-5p, and miR-4270) with high expression in MA samples, the PLF of serosa-invasive GC, and the CM of a highly metastatic GC cell line; these candidate miRNA species appear to be related to peritoneal dissemination. Differential expression of miR-21, miR-320c, and miR-1225-5p was validated in the PLF of serosa-invasive and non-invasive GC by qRT-PCR and miR-21 and miR-1225-5p were confirmed to be associated with serosal invasion in GC. PLF can be used to profile the expression of exosomal miRNAs. Our findings suggest that miR-21 and miR-1225-5p may serve as biomarkers of peritoneal recurrence after curative GC resection, thus providing a novel approach to early diagnosis of peritoneal dissemination of GC.
Conflict of interest statement
Figures
Similar articles
-
Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer.Cancer Lett. 2019 Aug 10;457:142-150. doi: 10.1016/j.canlet.2019.04.034. Epub 2019 May 8. Cancer Lett. 2019. PMID: 31075288
-
Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition.Cell Death Dis. 2018 Aug 28;9(9):854. doi: 10.1038/s41419-018-0928-8. Cell Death Dis. 2018. PMID: 30154401 Free PMC article.
-
Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.Gastric Cancer. 2016 Jul;19(3):744-53. doi: 10.1007/s10120-015-0521-0. Epub 2015 Aug 2. Gastric Cancer. 2016. PMID: 26233325
-
Candidate microRNA biomarkers in human gastric cancer: a systematic review and validation study.PLoS One. 2013 Sep 9;8(9):e73683. doi: 10.1371/journal.pone.0073683. eCollection 2013. PLoS One. 2013. PMID: 24040025 Free PMC article. Review.
-
Exosomes-microRNAs interacted with gastric cancer and its microenvironment: a mini literature review.Biomark Med. 2020 Feb;14(2):141-150. doi: 10.2217/bmm-2019-0387. Epub 2020 Feb 17. Biomark Med. 2020. PMID: 32064893 Review.
Cited by
-
miR-1286, a Tumor Suppressor of Gastric Cancer, Serves as a Promising Biomarker for Screening Gastric Cancer from Gastritis.Biochem Genet. 2024 Oct;62(5):3761-3773. doi: 10.1007/s10528-023-10618-z. Epub 2024 Jan 13. Biochem Genet. 2024. PMID: 38217797
-
Tumor-derived exosomes in cancer metastasis risk diagnosis and metastasis therapy.Clin Transl Oncol. 2019 Feb;21(2):152-159. doi: 10.1007/s12094-018-1918-0. Epub 2018 Jul 26. Clin Transl Oncol. 2019. PMID: 30051211 Review.
-
LINC00472 Acts as a Tumor Suppressor in NSCLC through KLLN-Mediated p53-Signaling Pathway via MicroRNA-149-3p and MicroRNA-4270.Mol Ther Nucleic Acids. 2019 Sep 6;17:563-577. doi: 10.1016/j.omtn.2019.06.003. Epub 2019 Jun 15. Mol Ther Nucleic Acids. 2019. Retraction in: Mol Ther Nucleic Acids. 2022 May 10;28:597. doi: 10.1016/j.omtn.2022.05.016 PMID: 31382188 Free PMC article. Retracted.
-
Exosomes: A Promising Avenue for the Diagnosis of Breast Cancer.Technol Cancer Res Treat. 2019 Jan 1;18:1533033818821421. doi: 10.1177/1533033818821421. Technol Cancer Res Treat. 2019. PMID: 30760122 Free PMC article. Review.
-
MiR-21 Is Required for the Epithelial-Mesenchymal Transition in MDA-MB-231 Breast Cancer Cells.Int J Mol Sci. 2021 Feb 4;22(4):1557. doi: 10.3390/ijms22041557. Int J Mol Sci. 2021. PMID: 33557112 Free PMC article.
References
-
- Carrington JC, Ambros V (2003) Role of microRNAs in plant and animal development. Science 301: 36–38. - PubMed
-
- Calin GA, Ferracin M, Cimmino A, Leva G, Shimizu M, Wojcik SE, et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793–1801. - PubMed
-
- Lorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065–7070. - PubMed
-
- Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834–838. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous